Stockholder's Equity (Tables)

6 Months Ended

Jun. 30, 2014

Stockholder's Equity.

Common stock outstanding

	Number of
	Common Shares
Balance at December 31, 2012	890,837
Conversion of Series E to common stock	1,575,000
Shares issued for acquisition of Canterbury and Hygeia	1,150,116
Conversion of warrants to common stock	1,023,264
Conversion of debt to common stock	576,331
Issuance of shares for advisory agreements	243,250
Issuance of shares to third party for assumption of liabilities	200,000
Issuance of common stock for cash	142,501
Other	12,486
Balance at December 31, 2013	5,813,785
Shares issued in private placement	8,845,685
Shares issued for acquisition of Paloma	2,500,000
Issuance of shares upon conversion of convertible promissory notes	552,738
Shares issued creditors in settlement of debt	408,317
Shares issued for acquisition of VasculoMedics	220,000
Issuance of shares for assumption of liabilities	150,000
Shares surrendered by ASC	(99,332	)
Balance at June 30, 2014 (Unaudited)	18,391,193

Stock Options- Assumptions

The assumptions used to value the options granted during the first six months of 2014 was:

Estimated fair value of underlying common stock	$ 2.50 - $4.20
Remaining life	2.0 - 3.0
Risk-free interest rate	0.88% - 1.72%
Expected volatility	153% - 176%
Dividend yield	—

Warrants -Assumptions

Estimated fair value of underlying common stock	$	3.00
Remaining life	5.0
Risk-free interest rate	0.35		%
Expected volatility	141		%
Dividend yield	—